Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Central Pharmaceuticals Revenue

Central Pharmaceuticals had revenue of 9.09M BDT in the quarter ending March 31, 2026, with 12.17% growth. This brings the company's revenue in the last twelve months to 36.10M. In the fiscal year ending June 30, 2025, Central Pharmaceuticals had annual revenue of 33.06M with 11.68% growth.

• Revenue (ttm): 36.10M
• Revenue Growth: +11.68%
• P/S Ratio: 30.87
• Revenue / Employee: 481.28K
• Employees: 75
• Market Cap: 1.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	33.06M	3.46M	11.68%
Jun 30, 2024	29.60M	271.46K	0.93%
Jun 30, 2023	29.33M	3.33M	12.81%
Jun 30, 2022	26.00M	-122.15M	-82.45%
Jun 30, 2021	148.15M	8.06M	5.75%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error